Age, years | 71.3 (4.8), 64–78 |
Sex, male/female (number) | 10/1 |
BMI, kg/m2 | 17.4 (1.9), 13.9–20.9 |
Cigarette smoking, pack years | 54.6 (24.7), 24.5–98 |
GOLD, III/IV, number | 6/5 |
Pulmonary function test | |
 FEV1, L | 0.82 (0.25), 0.41–1.29 |
 %FEV1, % predicted | 32.2 (9.4), 16.8–48.2 |
 FEV1/FVC, % | 34.3 (6.6), 22.9–46.0 |
 VC, L | 2.47 (0.57), 1.83–3.39 |
 %VC, % | 78.3 (15.7), 55.6–100.5 |
Incremental work rate exercise testing | |
 At peak exercise |  |
 Dyspnea, Borg scale | 5.8 (1.2), 4–7 |
 \( V_{{{\text{O}}_{2} }}^{{\prime }} \), mL/min/kg | 10.6 (2.6), 6.9–14.1 |
SGRQ | |
 Total score | 55.6 (17.7), 26.8–79.9 |
 Symptoms score | 67.5 (20.6), 19.1–92.0 |
 Activity score | 70.1 (13.1), 54.4–92.5 |
 Impacts score | 40.3 (22.4), 4.9–73.4 |
Medications (number) | |
 LAMA | 11 |
 LABA | 9 |
 ICS | 6 |
 Triple inhalation therapy | 5 |
 Methylxanthines | 0 |